Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis ; volume:12 ; number:1 ; day:17 ; month:9 ; year:2014 ; pages:1 ; date:9.2014
Pediatric rheumatology ; 12, Heft 1 (17.9.2014), 1, 9.2014
- Creator
-
Carolina Da Silva, Ana
Farias, A.
Sinicato, Nailu
Veloso, R.
Marini, Roberto
Appenzeller, Simone
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-12-S1-P199
- URN
-
urn:nbn:de:101:1-2021082219484460518372
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Carolina Da Silva, Ana
- Farias, A.
- Sinicato, Nailu
- Veloso, R.
- Marini, Roberto
- Appenzeller, Simone
- SpringerLink (Online service)
Other Objects (12)
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance